Natera Wins Cancer Test Injunction After $19M IP Verdict
By Dani Kass (December 1, 2023, 8:30 PM EST) -- A Delaware federal judge has barred Invitae Corp. from using its Personalized Cancer Monitoring test in certain ways that infringe patents owned by Natera Inc., according to a rare injunction made public Friday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.